| Jun 18 |
Vaxart anticipates funds to extend its cash runway into 2026
|
| Jun 17 |
Vaxart Provides Business Update
|
| Jun 14 |
Biggest stock movers today: ADBE, MSM, RH, and more
|
| Jun 14 |
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
|
| Jun 14 |
Vaxart to raise $40M via stock offering
|
| Jun 13 |
Vaxart Announces $40 Million Underwritten Offering of Common Stock
|
| Jun 13 |
Vaxart soars after hours on $453M award to evaluate COVID-19 oral pill vaccine candidate
|
| Jun 13 |
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
|
